SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-011507
Filing Date
2020-06-19
Accepted
2020-06-19 16:10:43
Documents
2
Period of Report
2020-06-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 1604
2 ex-24.htm EX-24 10398
  Complete submission text file 0001493152-20-011507.txt   13666
Mailing Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019
Business Address 1330 AVENUE OF THE AMERICAS, 33RD FLOOR NEW YORK NY 10019 646-813-4701
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

IRS No.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DYAX CORP. 300 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address
MIGAUSKY GEORGE V (Reporting) CIK: 0001134365 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 20975739